Gene: EMILIN3
Official Full Name: elastin microfibril interfacer 3provided by HGNC
Gene Summary: Enables identical protein binding activity. Located in collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23827 | EMILIN3 Knockout cell line (HEK293) | Human | EMILIN3 | 1:3~1:6 | Negative | Online Inquiry |
EMILIN3 Gene Knockout Cell Lines are advanced cellular models designed to facilitate in-depth research into the functions and biological roles of the EMILIN3 gene, which is critically involved in tissue remodeling and extracellular matrix dynamics. These cell lines have been genetically modified to disrupt the EMILIN3 gene, allowing researchers to study its absence in various biological contexts. By understanding the mechanisms behind EMILIN3's role in cellular processes such as adhesion, migration, and inflammation, scientists can gain insights into its implications in pathophysiological conditions, including cardiovascular diseases, cancer, and connective tissue disorders.
The primary mechanism of action of EMILIN3 involves its interactions with cellular receptors and signaling pathways that influence tissue homeostasis. In the knockout models, these interactions are fundamentally altered, providing clarity on how EMILIN3 regulates cellular behavior and affects the microenvironment. Such detailed analyses are essential for unraveling complex biological interactions and for developing targeted therapeutics.
The scientific importance of these cell lines is underscored by their applicability in both research and clinical settings. They serve as vital tools for researchers investigating the molecular basis of disease, allowing for high-throughput screening of compounds that could modulate the effects of the EMILIN3 absence. In a clinical context, these models can aid in the evaluation of potential therapies aimed at restoring normal function to tissues affected by EMILIN3 dysregulation.
Our EMILIN3 Gene Knockout Cell Lines stand out due to their specificity and reliability, offering a controlled system that eliminates the confounding variables present in traditional models. Compared to alternatives, these cell lines provide a precise platform for experimentation, ensuring reproducible results and enhanced data quality. The ability to observe the effects of gene knockout in real-time under various experimental conditions positions our cell lines as an invaluable resource for both academic and pharmaceutical research.
In summary, the EMILIN3 Gene Knockout Cell Lines are integral to advancing our understanding of gene function and its relevance to disease. They epitomize groundbreaking research tools, supported by our company's commitment to providing high-quality biological products that empower the scientific community. With our expertise in genetic engineering and cellular biology, we are dedicated to enhancing research outcomes and enabling novel therapeutic developments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.